249 related articles for article (PubMed ID: 15770053)
1. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.
Borazan A; Aydemir S; Sert M; Yilmaz A
Mediators Inflamm; 2004 Dec; 13(5-6):361-4. PubMed ID: 15770053
[TBL] [Abstract][Full Text] [Related]
2. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
3. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
4. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients.
Bekpinar S; Unlüçerçi Y; Genç S; Türkmen A
Adv Perit Dial; 2005; 21():80-4. PubMed ID: 16686291
[TBL] [Abstract][Full Text] [Related]
7. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
[TBL] [Abstract][Full Text] [Related]
8. Are the anticardiolipin antibodies a risk factor for coronary artery disease in chronic renal failure patients?
Ucar E; Kuvandik G; Sert M; Kuvandik C; Temizkan A; Borazan A
Ren Fail; 2008; 30(8):791-5. PubMed ID: 18791953
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia as a possible role for atherosclerosis in CAPD patients.
Kim SS; Hirose S; Tamura H; Nagasawa R; Tokushima H; Mitarai T; Isoda K
Adv Perit Dial; 1994; 10():282-5. PubMed ID: 7999846
[TBL] [Abstract][Full Text] [Related]
10. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
11. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.
Korevaar JC; van Manen JG; Dekker FW; de Waart DR; Boeschoten EW; Krediet RT;
J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945
[TBL] [Abstract][Full Text] [Related]
12. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients.
McIntyre C; Harper I; Macdougall IC; Raine AE; Williams A; Baker LR
Clin Nephrol; 1997 Dec; 48(6):371-4. PubMed ID: 9438096
[TBL] [Abstract][Full Text] [Related]
13. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
14. Association between white blood cell count and levels of serum homocysteine in end-stage renal failure patients treating with hemodialysis.
Bradran A; Nasri H
J Ayub Med Coll Abbottabad; 2006; 18(1):22-6. PubMed ID: 16773964
[TBL] [Abstract][Full Text] [Related]
15. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
Cavdar C; Sayan M; Sifil A; Artuk C; Yilmaz N; Bahar H; Camsari T
Scand J Urol Nephrol; 2003; 37(1):71-6. PubMed ID: 12745749
[TBL] [Abstract][Full Text] [Related]
16. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
[TBL] [Abstract][Full Text] [Related]
17. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
18. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.
Buccianti G; Baragetti I; Bamonti F; Furiani S; Dorighet V; Patrosso C
J Nephrol; 2004; 17(3):405-10. PubMed ID: 15365961
[TBL] [Abstract][Full Text] [Related]
19. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
[TBL] [Abstract][Full Text] [Related]
20. Determinants of coronary artery disease in nondiabetic hemodialysis patients: a matched case-control study.
Zumrutdal A; Baltali M; Micozkadioglu H; Torun D; Sezer S; Ozdemir FN; Haberal M
Ren Fail; 2007; 29(1):67-71. PubMed ID: 17365912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
